Company Update (NASDAQ:ALXN): FDA delays decision on key Alexion drug by 3 months

[Reuters] – Alexion Pharmaceuticals Inc said the U.S. Food and Drug Administration would delay by three months its decision on approving a key drug the company got through the acquisition of Synageva BioPharma . . . → Read More: Company Update (NASDAQ:ALXN): FDA delays decision on key Alexion drug by 3 months Similar Articles: Market Update: Alexion Pharmaceuticals Inc (NASDAQ:ALXN) – Alexion Pharmaceuticals to Report Second Quarter 2015 Results on Thursday, July 30, 2015 Market Update: Biogen Idec Inc (NASDAQ:BIIB) – Biogen says Tecfidera sales slow, delays data readout on Alzheimer’s drug Company Update: Alexion Pharmaceuticals Inc (NASDAQ:ALXN) – Alexion Pharmaceuticals to Report First Quarter 2015 Results on Thursday, April 23, 2015